(RTTNews) - AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with ...
Some results have been hidden because they may be inaccessible to you